Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hepatitis C Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hepatitis C Treatmentmarket, defines the market attractiveness level of Hepatitis C Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hepatitis C Treatment industry, describes the types of Hepatitis C Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hepatitis C Treatment market and the development prospects and opportunities of Hepatitis C Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hepatitis C Treatment market in Chapter 13.
By Player:
GlaxoSmith Kline Plc
Janssen Pharmaceuticals Inc
Bristol-Myers Squibb Company
AbbieVie Inc
Merck & Co Inc
Vertex Pharmaceuticals
Gilead Sciences Inc
F Hoffmann-La Roche AG
Schering AG
By Type:
HCV Protease Inhibitors
HCV Polymerase Inhibitors
HCV NS5A Inhibitors
Combination Therapy
Interferon and Antiviral
Others
By End-User:
Hospital
Clinic
Home Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hepatitis C Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hepatitis C Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hepatitis C Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hepatitis C Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hepatitis C Treatment Market Analysis and Outlook to 2022
-
7.1 Global Hepatitis C Treatment Consumption (2017-2022)
-
7.2 United States Hepatitis C Treatment Consumption (2017-2022)
-
7.3 Europe Hepatitis C Treatment Consumption (2017-2022)
-
7.4 China Hepatitis C Treatment Consumption (2017-2022)
-
7.5 Japan Hepatitis C Treatment Consumption (2017-2022)
-
7.6 India Hepatitis C Treatment Consumption (2017-2022)
-
7.7 South Korea Hepatitis C Treatment Consumption (2017-2022)
8 Region and Country-wise Hepatitis C Treatment Market Analysis and Outlook to 2028
-
8.1 Global Hepatitis C Treatment Consumption Forecast (2022-2028)
-
8.2 United States Hepatitis C Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Hepatitis C Treatment Consumption Forecast (2022-2028)
-
8.4 China Hepatitis C Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Hepatitis C Treatment Consumption Forecast (2022-2028)
-
8.6 India Hepatitis C Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Hepatitis C Treatment Consumption Forecast (2022-2028)
9 Global Hepatitis C Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Hepatitis C Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HCV Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global HCV Polymerase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global HCV NS5A Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Interferon and Antiviral Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hepatitis C Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)
10 Global Hepatitis C Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Hepatitis C Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global HCV Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global HCV Polymerase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global HCV NS5A Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Interferon and Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hepatitis C Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Hepatitis C Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hepatitis C Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hepatitis C Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hepatitis C Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hepatitis C Treatment Market Competitive Analysis
-
14.1 GlaxoSmith Kline Plc
-
14.1.1 GlaxoSmith Kline Plc Company Details
-
14.1.2 GlaxoSmith Kline Plc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmith Kline Plc Hepatitis C Treatment Product and Service
-
14.2 Janssen Pharmaceuticals Inc
-
14.2.1 Janssen Pharmaceuticals Inc Company Details
-
14.2.2 Janssen Pharmaceuticals Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Janssen Pharmaceuticals Inc Hepatitis C Treatment Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company Hepatitis C Treatment Product and Service
-
14.4 AbbieVie Inc
-
14.4.1 AbbieVie Inc Company Details
-
14.4.2 AbbieVie Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbieVie Inc Hepatitis C Treatment Product and Service
-
14.5 Merck & Co Inc
-
14.5.1 Merck & Co Inc Company Details
-
14.5.2 Merck & Co Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck & Co Inc Hepatitis C Treatment Product and Service
-
14.6 Vertex Pharmaceuticals
-
14.6.1 Vertex Pharmaceuticals Company Details
-
14.6.2 Vertex Pharmaceuticals Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Vertex Pharmaceuticals Hepatitis C Treatment Product and Service
-
14.7 Gilead Sciences Inc
-
14.7.1 Gilead Sciences Inc Company Details
-
14.7.2 Gilead Sciences Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Gilead Sciences Inc Hepatitis C Treatment Product and Service
-
14.8 F Hoffmann-La Roche AG
-
14.8.1 F Hoffmann-La Roche AG Company Details
-
14.8.2 F Hoffmann-La Roche AG Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 F Hoffmann-La Roche AG Hepatitis C Treatment Product and Service
-
14.9 Schering AG
-
14.9.1 Schering AG Company Details
-
14.9.2 Schering AG Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Schering AG Hepatitis C Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hepatitis C Treatment
-
Figure Hepatitis C Treatment Picture
-
Table Global Hepatitis C Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis C Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis C Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hepatitis C Treatment Consumption by Country (2017-2022)
-
Figure United States Hepatitis C Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Hepatitis C Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Hepatitis C Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Hepatitis C Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Hepatitis C Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hepatitis C Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Hepatitis C Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hepatitis C Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hepatitis C Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hepatitis C Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hepatitis C Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hepatitis C Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HCV Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global HCV Polymerase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global HCV NS5A Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon and Antiviral Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global HCV Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HCV Polymerase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HCV NS5A Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon and Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hepatitis C Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hepatitis C Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmith Kline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmith Kline Plc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmith Kline Plc Hepatitis C Treatment Product and Service
-
Table Janssen Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Inc Hepatitis C Treatment Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Hepatitis C Treatment Product and Service
-
Table AbbieVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbieVie Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbieVie Inc Hepatitis C Treatment Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Hepatitis C Treatment Product and Service
-
Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Hepatitis C Treatment Product and Service
-
Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Inc Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Inc Hepatitis C Treatment Product and Service
-
Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche AG Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche AG Hepatitis C Treatment Product and Service
-
Table Schering AG (Foundation Year, Company Profile and etc.)
-
Table Schering AG Hepatitis C Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Schering AG Hepatitis C Treatment Product and Service
-
